InsiderOther
Linda Llewelyn Insider Trading Activity
Every SEC Form 4 transaction reported by Linda Llewelyn, sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Is Linda Llewelyn buying or selling?
Linda Llewelyn reported 0 open-market buys ($0) and 58 sells ($3.7M) across 58 Form 4 filings at 1 company — a net selling position of $3.7M.
Source: SEC EDGAR Form 4
Key Statistics (as of Feb 21, 2025)
Total Form 4 filings
58
SEC EDGAR
Companies
1
Buys (0)
$0
Sells (58)
$3.7M
Insider sentiment
Net sellingNet insider flow of $3.7M in net selling, filed between Mar 6, 2020 – Feb 21, 2025.
Companies Linda Llewelyn files for
| # | Company | Form 4 filings |
|---|---|---|
| 1 | HCATHealth Catalyst, Inc. | 58 |
Recent Linda Llewelyn transactions
| Date | Ticker | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| Feb 21, 2025 | HCAT | Chief People Officer | Sale | 6.4K | $35.0K |
| Jan 18, 2025 | HCAT | Chief People Officer | Sale | 6.4K | $37.3K |
| Dec 18, 2024 | HCAT | Chief People Officer | Sale | 6.4K | $50.8K |
| Nov 18, 2024 | HCAT | Chief People Officer | Sale | 1.4K | $11.6K |
| Oct 17, 2024 | HCAT | Chief People Officer | Sale | 1.3K | $10.8K |
| Sep 18, 2024 | HCAT | Chief People Officer | Sale | 1.3K | $11.2K |
| Aug 16, 2024 | HCAT | Chief People Officer | Sale | 1.3K | $8.7K |
| Jul 17, 2024 | HCAT | Chief People Officer | Sale | 1.3K | $8.4K |
| Jun 21, 2024 | HCAT | Chief People Officer | Sale | 1.3K | $8.2K |
| May 20, 2024 | HCAT | Chief People Officer | Sale | 2.1K | $14.5K |
| Apr 17, 2024 | HCAT | Chief People Officer | Sale | 2.0K | $12.3K |
| Mar 19, 2024 | HCAT | Chief People Officer | Sale | 2.0K | $15.6K |
| Feb 20, 2024 | HCAT | Chief People Officer | Sale | 3.3K | $31.9K |
| Jan 18, 2024 | HCAT | Chief People Officer | Sale | 3.2K | $34.2K |
| Dec 19, 2023 | HCAT | Chief People Officer | Sale | 3.2K | $27.9K |
| Nov 17, 2023 | HCAT | Chief People Officer | Sale | 1.2K | $9.9K |
| Oct 20, 2023 | HCAT | Chief People Officer | Sale | 1.2K | $9.7K |
| Sep 19, 2023 | HCAT | Chief People Officer | Sale | 1.2K | $12.8K |
| Aug 24, 2023 | HCAT | Chief People Officer | Sale | 737 | $8.8K |
| Feb 18, 2023 | HCAT | Chief People Officer | Sale | 662 | $9.1K |
| Jan 19, 2023 | HCAT | Chief People Officer | Sale | 642 | $7.8K |
| Dec 20, 2022 | HCAT | Chief People Officer | Sale | 642 | $7.1K |
| Nov 17, 2022 | HCAT | Chief People Officer | Sale | 669 | $7.2K |
| Oct 20, 2022 | HCAT | Chief People Officer | Sale | 648 | $6.2K |
| Sep 19, 2022 | HCAT | Chief People Officer | Sale | 648 | $7.1K |
Showing the 25 most recent filings of 58. Screen every filing.
Linda Llewelyn insider trading FAQ
Is Linda Llewelyn buying or selling?
Across 58 SEC Form 4 filings, Linda Llewelyn reported 0 open-market purchases totaling $0 and 58 sales totaling $3.7M — a net selling position of $3.7M.
Which companies does Linda Llewelyn file Form 4s for?
Linda Llewelyn has reported insider transactions at 1 company, most often Health Catalyst, Inc. (HCAT).
How far back does Linda Llewelyn's filing history go?
Trabud holds Linda Llewelyn's SEC Form 4 filings from Mar 6, 2020 – Feb 21, 2025, sourced directly from SEC EDGAR.
Where does Trabud get Linda Llewelyn's insider trading data?
Directly from SEC EDGAR Form 4 filings. Every transaction on this page is a real filing accepted by the SEC, updated as new filings arrive.
Related Content
Track Linda Llewelyn and every other insider
Screen all SEC Form 4 filings by insider, company, transaction value, and role — or ask Trabud's AI agent in plain English.
Open the screener